Assessment of Intrafractional Displacements in Surface-Guided Inspiration Breath-Hold Stereotactic Body Radiation Therapy
DOI:
https://doi.org/10.55378/rv.50.2.2Keywords:
IBH, SBRT, SGRTAbstract
Abstract
Background: Stereotactic Body Radiation Therapy (SBRT) delivers high radiation doses to tumours with steep dose gradients, minimizing exposure to surrounding healthy tissues. Surface-guided Inspiration Breath-Hold (IBH) is particularly useful for thoracic and upper abdominal tumours, where respiratory motion can affect target position.
Aim: This retrospective cohort study aimed to assess whether GTV or anatomical surrogate intrafractional displacement during surface-guided IBH remains ≤0.5 cm when surface guidance confirms reproducible breath-hold throughout treatment. The study also evaluated the accuracy and precision of an SBRT protocol using IBH monitored by Surface Guided Radiation Therapy (SGRT). Intrafractional displacement was compared between lung and liver cohorts.
Materials and Methods: Offline reviews were performed for 86 lung SBRT patients (182 fractions) and 124 liver SBRT patients (159 fractions).
Results: In the liver cohort, the greatest mean intrafractional displacement was observed in the vertical (VRT) direction (0.087 cm), while mean shifts in lateral (LAT) and longitudinal (LNG) directions were -0.031 cm and -0.042 cm, respectively. The highest SD was observed in LNG (±0.275 cm). Mean 3D displacement was 0.351 ± 0.181 cm.
In the lung cohort, the greatest mean displacement was observed in the LNG direction (-0.092 cm), followed by LAT (-0.025 cm) and VRT (0.036 cm). The highest SD was also observed in LNG (±0.251 cm). Mean 3D displacement was 0.298 ± 0.186 cm.
Significant differences between liver and lung cohorts were observed for VRT, LNG, and 3D displacement (p=0.0140, p=0.0331, and p=0.0032, respectively).
Conclusion: The hypothesis that intrafractional displacement during surface-guided IBH is consistently ≤0.5 cm was not confirmed. Nevertheless, the protocol provided adequate geometric accuracy for most treatments, demonstrating high positional stability during SBRT. Significant differences between lung and liver cohorts suggest that region-specific considerations may be warranted when applying surface-guided IBH SBRT
References
[1] H. Sung et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA Cancer J. Clin., vol. 71, no. 3, pp. 209–249, May 2021, doi: 10.3322/CAAC.21660.
[2] R. Baskar, K. A. Lee, R. Yeo, and K. W. Yeoh, “Cancer and Radiation Therapy: Current Advances and Future Directions,” Int. J. Med. Sci., vol. 9, no. 3, p. 193, Feb. 2012, doi: 10.7150/IJMS.3635.
[3] S. R. Mehta, V. Suhag, M. Semwal, and N. Sharma, “Radiotherapy: Basic Concepts and Recent Advances,” Med. J. Armed Forces India, vol. 66, no. 2, p. 158, 2011, doi: 10.1016/S0377-1237(10)80132-7.
[4] S. Abel, S. Lee, E. B. Ludmir, and V. Verma, “Principles and Applications of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy,” Hematol. Oncol. Clin. North Am., vol. 33, no. 6, pp. 977–987, Dec. 2019, doi: 10.1016/J.HOC.2019.08.007.
[5] B. Qiu, A. Aili, L. Xue, P. Jiang, and J. Wang, “Advances in Radiobiology of Stereotactic Ablative Radiotherapy,” Front. Oncol., vol. 10, p. 1165, Aug. 2020, doi: 10.3389/FONC.2020.01165.
[6] L. Kollar and R. Rengan, “Stereotactic Body Radiotherapy,” Semin. Oncol., vol. 41, no. 6, pp. 776–789, Dec. 2014, doi: 10.1053/J.SEMINONCOL.2014.09.022.
[7] P. Burkoň et al., “Stereotactic Body Radiotherapy - Current Indications,” Klin. Onkol., vol. 32, no. 1, pp. 10–24, 2019, doi: 10.14735/AMKO201910.
[8] L. Ceniceros et al., “Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients,” Clin. Transl. Oncol., vol. 18, no. 3, pp. 259–268, Mar. 2016, doi: 10.1007/S12094-015-1361-4.
[9] J. Roesch, N. Andratschke, and M. Guckenberger, “SBRT in operable early stage lung cancer patients,” Transl. Lung Cancer Res., vol. 3, no. 4, pp. 212–224, 2014, doi: 10.3978/J.ISSN.2218-6751.2014.08.06.
[10] E. Gutiérrez et al., “Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases,” Current Oncology, vol. 28, no. 4, p. 2560, Aug. 2021, doi: 10.3390/CURRONCOL28040233.
[11] J. Wang et al., “Medical Dosimetry Application and dosimetric comparison of surface-guided deep inspiration breath-hold for lung stereotactic body radiotherapy including those for text and data mining, AI training, and similar technologies,” Medical Dosimetry, vol. 49, pp. 372–379, 2024, doi: 10.1016/j.meddos.2024.05.003.
[12] M. Miften et al., “Radiation Dose-Volume Effects for Liver SBRT,” Int. J. Radiat. Oncol. Biol. Phys., vol. 110, no. 1, pp. 196–205, May 2021, doi: 10.1016/j.ijrobp.2017.12.290.
[13] H. Doi, N. Beppu, K. Kitajima, and K. Kuribayashi, “Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives”, doi: 10.21873/anticanres.12263.
[14] M. Kurzyński, M. Urbańska-Gąsiorowska, and M. Hetnał, “Stereotactic irradiation of liver tumors – is it worthwhile?,” Nowotwory. Journal of Oncology, vol. 74, no. 1, pp. 42–48, 2024, doi: 10.5603/NJO.97775.
[15] Y. Matsuo, “Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview,” Current Oncology, vol. 30, no. 2, p. 2493, Feb. 2023, doi: 10.3390/CURRONCOL30020190.
[16] S. H. Bae et al., “Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines,” Int. J. Radiat. Oncol. Biol. Phys., vol. 118, no. 2, pp. 337–351, Feb. 2024, doi: 10.1016/J.IJROBP.2023.08.015/ATTACHMENT/B327E8AE-A39C-49D6-A3C6-1E2E30B6898D/MMC2.DOCX.
[17] R. Frakulli et al., “Stereotactic body radiation therapy in cholangiocarcinoma: A systematic review,” British Journal of Radiology, vol. 92, no. 1097, p. 20180688, 2019, doi: 10.1259/BJR.20180688/SUPPL_FILE/BJR.20180688.SUPPL-01.DOCX.
[18] A. Mahadevan et al., “Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry,” Radiation Oncology, vol. 13, no. 1, pp. 1–11, Feb. 2018, doi: 10.1186/S13014-018-0969-2/TABLES/2.
[19] P. Naumann et al., “Feasibility of Optical Surface-Guidance for Position Verification and Monitoring of Stereotactic Body Radiotherapy in Deep-Inspiration Breath-Hold,” Front. Oncol., vol. 10, Sep. 2020, doi: 10.3389/FONC.2020.573279.
[20] C. M. Burman, “Immobilization and Simulation,” Leibel and Phillips Textbook of Radiation Oncology, Third Edition, pp. 193–212, Jan. 2010, doi: 10.1016/B978-1-4160-5897-7.00011-1.
[21] “Edge | Varian.” Accessed: Jul. 19, 2025. [Online]. Available: https://www.varian.com/products/radiosurgery/treatment-delivery/edge
[22] S. A. Jupitz, A. J. Shepard, P. M. Hill, and B. P. Bednarz, “Investigation of tumor and vessel motion correlation in the liver,” J. Appl. Clin. Med. Phys., vol. 21, no. 8, pp. 183–190, Aug. 2020, doi: 10.1002/ACM2.12943.
[23] “R: The R Project for Statistical Computing.” Accessed: Jun. 07, 2025. [Online]. Available: https://www.r-project.org/
[24] E. Brown, E. Muscat, P. O’Connor, H. Liu, Y. Y. Lee, and D. Pryor, “Intrafraction cone beam computed tomography verification of breath hold during liver stereotactic radiation therapy,” J. Med. Radiat. Sci., vol. 68, no. 1, p. 52, Mar. 2020, doi: 10.1002/JMRS.441.
[25] D. Nguyen et al., “Reproducibility of surface-based deep inspiration breath-hold technique for lung stereotactic body radiotherapy on a closed-bore gantry linac,” Phys. Imaging Radiat. Oncol., vol. 26, p. 100448, Apr. 2023, doi: 10.1016/J.PHRO.2023.100448.
[26] L. B. Stick, I. R. Vogelius, S. Risum, and M. Josipovic, “Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold,” Br. J. Radiol., vol. 93, no. 1116, p. 20200859, Dec. 2020, doi: 10.1259/BJR.20200859.
[27] C. Zeng et al., “Intrafractional accuracy and efficiency of a surface imaging system for deep inspiration breath hold during ablative gastrointestinal cancer treatment,” J. Appl. Clin. Med. Phys., vol. 23, no. 11, p. e13740, Nov. 2022, doi: 10.1002/ACM2.13740.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Domagoj Brkić, MSc (Author); Dr. Damir Vučinić, MD, PhD, Ivana Alerić, univ. mag. educ. phys. et inf., Vanda Leipold, mag. educ. phys. et inf., Dr. Hrvoje Kaučić, MD, PhD

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
CART